• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Completion of guideline-recommended initial evaluation of atrial fibrillation.完成房颤初始评估的指南推荐。
Clin Cardiol. 2012 Oct;35(10):585-93. doi: 10.1002/clc.22055. Epub 2012 Sep 13.
2
Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.商业保险人群中房颤治疗实践模式的评估。
Curr Med Res Opin. 2014 Sep;30(9):1707-13. doi: 10.1185/03007995.2014.922061. Epub 2014 Jun 2.
3
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.1993 - 2007年医疗保险受益人心房颤动的发病率、患病率及相关死亡率
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
4
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.在新诊断为心房颤动的 Medicare 受益人群中,心血管住院的负担、时间和与死亡率的关系。
Am Heart J. 2013 Sep;166(3):573-80. doi: 10.1016/j.ahj.2013.07.003. Epub 2013 Aug 12.
5
National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries.老年心房颤动患者华法林使用的国家利用模式:医疗保险处方药受益人的基于人群的研究。
Ann Pharmacother. 2013 Jan;47(1):35-42. doi: 10.1345/aph.1R515. Epub 2013 Jan 16.
6
Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.意大利初级保健医生对心房颤动的诊断和管理:一项回顾性、观察性分析。
Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.
7
Appropriate use of anti-thrombotic therapy in patients with atrial fibrillation at single-center experience, Northwest Ethiopia.在埃塞俄比亚西北部的单中心经验中,适当使用抗血栓治疗心房颤动患者。
BMC Cardiovasc Disord. 2020 Aug 17;20(1):375. doi: 10.1186/s12872-020-01659-y.
8
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.心房颤动和心房扑动患者的预后和指南一致的抗血栓治疗:真实临床实践中治疗不足和过度治疗的影响;卢瓦尔河谷心房颤动项目。
Chest. 2011 Oct;140(4):911-917. doi: 10.1378/chest.10-2436. Epub 2011 Mar 24.
9
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).需要紧急医疗护理的心房颤动。各收治科室的处理方法及结果。来自意大利心房颤动/扑动注册研究(FIRE)的数据。
Ital Heart J. 2004 Mar;5(3):205-13.
10
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.欧洲心脏病学会指南指导下的抗栓治疗改善了高危房颤患者的预后:来自 EORP-AF 一般试点登记处的报告。
Europace. 2015 Dec;17(12):1777-86. doi: 10.1093/europace/euv269. Epub 2015 Aug 30.

引用本文的文献

1
Women and atrial fibrillation.女性与心房颤动。
J Cardiovasc Electrophysiol. 2021 Oct;32(10):2793-2807. doi: 10.1111/jce.14838. Epub 2020 Dec 29.
2
Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018.2006 年至 2018 年,在综合医疗保健提供系统中,房颤发病率的趋势。
JAMA Netw Open. 2020 Aug 3;3(8):e2014874. doi: 10.1001/jamanetworkopen.2020.14874.
3
Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.新诊断心房颤动患者华法林治疗窗时间的临床预测模型。
J Am Heart Assoc. 2017 Oct 12;6(10):e006669. doi: 10.1161/JAHA.117.006669.
4
Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue.胸腺肽 β4 涂层纳米纤维支架修复受损的心脏组织。
J Nanobiotechnology. 2014 Mar 24;12:10. doi: 10.1186/1477-3155-12-10.

本文引用的文献

1
All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation.接受华法林治疗的房颤患者的全因及出血相关医疗费用。
J Manag Care Pharm. 2011 Nov;17(9):672-84. doi: 10.18553/jmcp.2011.17.9.672.
2
Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.接受导管消融治疗的心房颤动患者的医疗利用和支出。
J Cardiovasc Electrophysiol. 2012 Jan;23(1):1-8. doi: 10.1111/j.1540-8167.2011.02130.x. Epub 2011 Jul 21.
3
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.新型房颤抗凝出血风险评分对预测抗凝出血风险的比较验证:HAS-BLED(高血压、肾功能/肝功能异常、卒中、出血史或倾向、INR 易变、高龄、同时使用药物/酒精)评分。
J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24.
4
Racial variation in medical outcomes among living kidney donors.活体肾捐献者的医疗结果中的种族差异。
N Engl J Med. 2010 Aug 19;363(8):724-32. doi: 10.1056/NEJMoa1000950.
5
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).心房颤动管理指南:欧洲心脏病学会(ESC)心房颤动管理特别工作组
Eur Heart J. 2010 Oct;31(19):2369-429. doi: 10.1093/eurheartj/ehq278. Epub 2010 Aug 29.
6
Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED.急诊新发性心房颤动患者常规促甲状腺激素测定的效用。
Am J Emerg Med. 2011 Nov;29(9):1158-62. doi: 10.1016/j.ajem.2010.06.010. Epub 2010 Aug 13.
7
Comparing treatment trends for colorectal cancer in clinical database and cancer registry data: implications for monitoring cancer care.比较临床数据库和癌症登记数据中结直肠癌的治疗趋势:对癌症护理监测的影响。
J Eval Clin Pract. 2011 Jun;17(3):486-92. doi: 10.1111/j.1365-2753.2010.01467.x. Epub 2010 Jul 8.
8
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap.美国前列腺癌治疗的模式和质量存在种族差异:注意差距。
BJU Int. 2010 Aug;106(3):322-8. doi: 10.1111/j.1464-410X.2010.09467.x. Epub 2010 Jun 14.
9
Geographic differences in use of home oxygen for obstructive lung disease: a national Medicare study.阻塞性肺疾病家庭氧疗使用的地域差异:一项全国性的医疗保险研究。
J Rural Health. 2010 Summer;26(2):139-45. doi: 10.1111/j.1748-0361.2010.00275.x.
10
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.一种新型的便于使用的评分(HAS-BLED),用于评估心房颤动患者 1 年内大出血的风险:欧洲心脏调查。
Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18.

完成房颤初始评估的指南推荐。

Completion of guideline-recommended initial evaluation of atrial fibrillation.

机构信息

Framingham Heart Study, Framingham, Massachusetts, USA.

出版信息

Clin Cardiol. 2012 Oct;35(10):585-93. doi: 10.1002/clc.22055. Epub 2012 Sep 13.

DOI:10.1002/clc.22055
PMID:22976579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3652268/
Abstract

BACKGROUND

Guidelines recommend evaluation of cardiac function, valvular and ischemic heart disease, and thyroid, kidney, and liver function on initial diagnosis of atrial fibrillation (AF).

HYPOTHESIS

We hypothesized that initial workup of patients with newly identified AF would vary by age, sex, and burden of comorbid illness.

METHODS

In a retrospective analysis of a large sample of commercially insured patients 18 to 64 years old (n = 40 245) and a nationally representative 5% cohort of Medicare beneficiaries 65 years or older (n = 204 676), we measured claims for guideline-recommended services for initial evaluation of AF among patients with a new diagnosis between 2000 and 2008.

RESULTS

From 30 days before through 90 days after AF diagnosis, basic evaluation, including physician visit, electrocardiogram, and echocardiography, was completed in up to 66.6% of patients. Completion rates for all guideline-recommended evaluations were 17.4% in the commercially insured sample and 18.5% in the Medicare cohort in 2007. Evaluation rates increased over time. Blood tests assessing thyroid function were documented for approximately one-third of patients in each cohort. Increasing the observation period to 1 year before through 3 months after the AF diagnosis markedly increased completion rates, but rates of thyroid function testing remained low (50%-60%). There were minor differences in evaluation completeness by sex, race, and geographic region.

CONCLUSIONS

Differences in guideline-recommended evaluation rates by demographic characteristics after a new diagnosis of AF were of minor clinical importance. Basic evaluation had satisfactory completion rates; however, rates of laboratory testing were low.

摘要

背景

指南建议在诊断心房颤动(AF)时评估心功能、瓣膜和缺血性心脏病以及甲状腺、肾脏和肝功能。

假设

我们假设在新诊断的 AF 患者中,初始检查会因年龄、性别和合并症负担而异。

方法

在对大量商业保险患者(18-64 岁,n=40245)和全国代表性的 Medicare 受益人群 5%队列(65 岁或以上,n=204676)的回顾性分析中,我们测量了在 2000 年至 2008 年期间新诊断为 AF 的患者中,指南推荐的初始评估服务的索赔情况。

结果

从 AF 诊断前 30 天到诊断后 90 天,多达 66.6%的患者完成了基本评估,包括医生就诊、心电图和超声心动图。在商业保险样本中,2007 年所有指南推荐评估的完成率为 17.4%,在 Medicare 队列中为 18.5%。评估率随时间增加而增加。每个队列中约有三分之一的患者进行了评估甲状腺功能的血液检查。将观察期延长至 AF 诊断前 1 年至诊断后 3 个月,显著提高了完成率,但甲状腺功能检查率仍然较低(50%-60%)。在性别、种族和地理区域方面,评估的完整性存在微小差异。

结论

新诊断为 AF 后,根据人口统计学特征评估率的差异具有较小的临床意义。基本评估的完成率令人满意,但实验室检查率较低。